BIO-RAD LABORATORIES, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
BIO-RAD LABORATORIES, INC. (BIO.B) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $2.00M, a 94.74% decline year-over-year.
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $2.30M, a 9.52% increase year-over-year.
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was -$1.10M, a 126.19% decline year-over-year.
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $1.70M, a 1600.00% increase year-over-year.
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $40.70M, a 162.58% increase from fiscal 2024.
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $15.50M, a 71.14% decline from fiscal 2023.
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $53.70M, a 153.30% increase from fiscal 2022.
- BIO-RAD LABORATORIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $21.20M, a 53.41% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-08-04 | $4.30M 10-Q · filed 2026-08-04 | $3.20M derived: sum of 3 quarters · filed 2026-08-04 | $4.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $2.30M 10-Q · filed 2026-04-30 | $1.20M derived: sum of 2 quarters · filed 2026-04-30 | $2.90M derived: sum of 3 quarters · filed 2026-04-30 | $40.90M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $600.00K derived: sum of 2 quarters · filed 2026-02-13 | $38.60M derived: sum of 3 quarters · filed 2026-08-04 | $40.70M 10-K · filed 2026-02-13 |
| 2025-09-30 | $1.70M 10-Q · filed 2025-10-29 | $39.70M derived: sum of 2 quarters · filed 2026-08-04 | $41.80M 10-Q · filed 2025-10-29 | $46.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $38.00M 10-Q · filed 2026-08-04 | $40.10M 10-Q · filed 2026-08-04 | $44.30M derived: sum of 3 quarters · filed 2026-08-04 | $44.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.10M 10-Q · filed 2026-04-30 | $6.30M derived: sum of 2 quarters · filed 2026-04-30 | $6.40M derived: sum of 3 quarters · filed 2026-04-30 | $10.10M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $4.30M derived: sum of 2 quarters · filed 2026-02-13 | $8.00M derived: sum of 3 quarters · filed 2026-02-13 | $15.50M 10-K · filed 2026-02-13 |
| 2024-09-30 | $100.00K 10-Q · filed 2025-10-29 | $3.80M derived: sum of 2 quarters · filed 2025-10-29 | $11.30M 10-Q · filed 2025-10-29 | $16.10M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $3.70M 10-Q · filed 2025-07-31 | $11.20M 10-Q · filed 2025-07-31 | $16.00M derived: sum of 3 quarters · filed 2026-02-13 | $52.70M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $7.60M 10-Q · filed 2025-05-01 | $12.30M derived: sum of 2 quarters · filed 2026-02-13 | $49.00M derived: sum of 3 quarters · filed 2026-02-13 | $59.10M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $41.40M derived: sum of 2 quarters · filed 2026-02-13 | $51.50M derived: sum of 3 quarters · filed 2026-02-13 | $53.70M 10-K · filed 2026-02-13 |
| 2023-09-30 | $36.70M 10-Q · filed 2024-10-31 | $46.80M derived: sum of 2 quarters · filed 2024-10-31 | $49.00M 10-Q · filed 2024-10-31 | $60.80M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $10.10M 10-Q · filed 2024-08-02 | $12.30M 10-Q · filed 2024-08-02 | $24.10M derived: sum of 3 quarters · filed 2025-02-14 | $26.40M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $2.20M 10-Q · filed 2024-05-08 | $14.00M derived: sum of 2 quarters · filed 2025-02-14 | $16.30M derived: sum of 3 quarters · filed 2025-02-14 | $17.90M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $11.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $14.10M derived: sum of 2 quarters · filed 2025-02-14 | $15.70M derived: sum of 3 quarters · filed 2025-02-14 | $21.20M 10-K · filed 2025-02-14 |
| 2022-09-30 | $2.30M 10-Q · filed 2023-10-27 | $3.90M derived: sum of 2 quarters · filed 2023-10-27 | $9.40M 10-Q · filed 2023-10-27 | $42.60M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $1.60M 10-Q · filed 2023-08-04 | $7.10M 10-Q · filed 2023-08-04 | $40.30M derived: sum of 3 quarters · filed 2024-02-16 | $46.10M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $5.50M 10-Q · filed 2023-05-05 | $38.70M derived: sum of 2 quarters · filed 2024-02-16 | $44.50M derived: sum of 3 quarters · filed 2024-02-16 | $46.80M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $33.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $39.00M derived: sum of 2 quarters · filed 2024-02-16 | $41.30M derived: sum of 3 quarters · filed 2024-02-16 | $45.50M 10-K · filed 2024-02-16 |
| 2021-09-30 | $5.80M 10-Q · filed 2022-10-28 | $8.10M derived: sum of 2 quarters · filed 2022-10-28 | $12.30M 10-Q · filed 2022-10-28 | $20.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $2.30M 10-Q · filed 2022-07-29 | $6.50M 10-Q · filed 2022-07-29 | $14.20M derived: sum of 3 quarters · filed 2023-02-17 | $15.00M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $4.20M 10-Q · filed 2022-04-29 | $11.90M derived: sum of 2 quarters · filed 2023-02-17 | $12.70M derived: sum of 3 quarters · filed 2023-02-17 | $14.90M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $8.50M derived: sum of 2 quarters · filed 2023-02-17 | $10.70M derived: sum of 3 quarters · filed 2023-02-17 | $16.10M 10-K · filed 2023-02-17 |
| 2020-09-30 | $800.00K 10-Q · filed 2021-10-29 | $3.00M derived: sum of 2 quarters · filed 2021-10-29 | $8.40M 10-Q · filed 2021-10-29 | $22.30M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $2.20M 10-Q · filed 2021-07-30 | $7.60M 10-Q · filed 2021-07-30 | $21.50M derived: sum of 3 quarters · filed 2022-02-11 | $35.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $10.80M 10-Q · filed 2021-04-30 | $19.30M derived: sum of 2 quarters · filed 2022-02-11 | $33.70M derived: sum of 3 quarters · filed 2022-02-11 | $38.20M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $22.90M derived: sum of 2 quarters · filed 2022-02-11 | $27.40M derived: sum of 3 quarters · filed 2022-02-11 | $28.70M 10-K · filed 2022-02-11 |
| 2019-09-30 | $14.40M 10-Q · filed 2020-10-30 | $18.90M derived: sum of 2 quarters · filed 2020-10-30 | $20.20M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $4.50M 10-Q · filed 2020-07-31 | $5.80M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $1.40M 10-Q · filed 2020-05-08 |